KaNDy Therapeutics
Stevenage
About KaNDy Therapeutics
KaNDy Therapeutics is a provider of bio-technical research and development services intended to offer treatment for common, chronic debilitating female sex hormone-related conditions. The company's services offer non-hormonal therapy to treat moderate to severe post-menopausal vasomotor symptoms, enabling patients to receive treatment and reduce symptoms of hormone-related conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $32.6M
- Funding stage: M&A
- Last round: Series C (Aug 2018)
- Website: kandytherapeutics.com
- Phone: +44 (0) 1438 906 960
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/kandy-therapeutics-40647 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.